K Merkle

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Wolfgang Knauf, Toshko Lissichkov, Ali Aldaoud et al. · Journal of Clinical Oncology · 2009 · 439 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

Wolfram Pönisch, Paris S. Mitrou, K Merkle et al. · Journal of Cancer Research and Clinical Oncology · 2006 · 192 citations · Full text

Medicine, Hematology, Oncology +13

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase <scp>III</scp> trial

Wolfgang Knauf, Toshko Lissitchkov, Ali Aldaoud et al. · British Journal of Haematology · 2012 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours

Marika Rasschaert, D. Schrijvers, Jan Van den Brande et al. · British Journal of Cancer · 2007 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Bendamustine Versus Chlorambucil in Treatment-Naive Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results of an International Phase III Study.

Wolfgang Knauf, Toshko Lissichkov, Ali Aldaoud et al. · Blood · 2007 · 46 citations

Medicine, Hematology, Oncology +13